Technology3 weeks ago
Calidi Biotherapeutics Shares Drop 35% Following Public Offering Announcement
Shares of Calidi Biotherapeutics Inc. (NYSE: CLDI) experienced a significant decline of 35.04% in after-hours trading on Thursday, falling to $0.50. This drop occurred after the...